Membres du comité organisateur

Coprésidents du congrès

Pierre Côté

Jean-Pierre Routy

Coprésidents du volet Sciences fondamentales

Bluma G. Brenner

Dr. Bluma Brenner, chercheur dans le domaine du VIH depuis 2004, collabore avec Mark A. Wainberg, étudiant divers aspects de la résistance du VIH aux médicaments ainsi que le rôle multidimensionnel de la résistance et sous-type sur la sensibilité aux médicaments antirétroviraux et l’adaptabilité virale. Elle est coordinatrice du programme de génotypage de la résistance aux antirétroviraux. Elle a récemment reçu des subventions des IRSC et NIH pour étudier la dynamique de la transmission par surveillance populationnelle et pour mettre au point des stratégies de prévention. Elle a également été impliquée dans la création de SPOT, offrant des services de dépistage anonyme et de conseil dans un site communautaire à Montréal.

Éric A. Cohen

Dr. Éric A. Cohen received a B.Sc. in biochemistry from McGill University (1981), and a Ph.D. in Molecular Biology from l'Université de Montréal (1987). Dr. Cohen has been involved in the study of Human Immunodeficiency Virus (HIV) and AIDS since 1986 when he began a postdoctoral fellowship at the Dana Farber Cancer Institute and at the department of Pathology of Harvard Medical School. His original interest, which centered on the mechanisms regulating the replication of retroviruses causing immunodeficiencies in humans, led to the discovery of two HIV proteins - Vpr and Vpu. Dr Cohen is currently head of the Laboratory of Human Retrovirology and Director of the Immunity and Viral Infection research axis at the Institut de Recherches Cliniques de Montréal (IRCM). He is also Professor of Virology at the department of Microbiology and Immunology at l’Université de Montréal and recipient of the Canada Research Chair in Human Retrovirology. Additionally, Dr Cohen holds an appointment as Adjunct Professor at the Division of Experimental Medicine of McGill University. Dr Cohen current research interests focus primarily on HIV-host interactions governing viral replication and transmission and the development of therapeutic approach aimed at suppressing HIV infection. He has authored over 120 original manuscripts and presented at major national and international HIV/AIDS meetings. Dr. Cohen is a member of numerous professional societies, editorial boards and peer review committees.

Coprésidentes du volet Sciences cliniques

Francois Coutlée

Francois Coutlée est microbiologiste-infectiologue au Centre Hospitalier de l’Université de Montréal et est professeur titulaire au département de Microbiologie-Immunologie de l’Université de Montréal. Il dirige un programme de recherche supporté par les IRSC, le FRSQ et la Société de Recherche sur le Cancer portant sur les biomarqueurs de l’infections au virus du papillome humain du développement de lésions précancéreuses et cancéreuses au niveau des voies génitales des femmes et des hommes. Il travaille plus particulièerement sur l’évolution, le diagnostic et le traitement des lésions anales causées par les papullomavirus des hommes et des femmes infectés par le VIH.

Richard G Lalonde

Coprésidents du volet Épidémiologie et sciences de la santé publique

Dr Julie Bruneau is a clinical researcher and Professor in the Department of Family Medicine at the University of Montreal. She is a FRSQ senior clinical research Scholar. As a clinician, she is recognized as a leader in the development of addiction medicine in Canada. For the past twenty years, she has conducted epidemiological research among active injecting drug users (IDU), and published her work in high-impact journals. Her research accomplishments have significantly contributed to a better understanding of the dynamics of HIV and HCV transmission among IDUs. Her work on the relation between syringe access and HIV transmission, albeit controversial at times, directly influenced changes in prevention strategies to better address injector needs nationally and around the world.

Nitika Pant Pai

An Assistant Professor of Medicine in the Division of Clinical Epidemiology & Infectious Diseases at McGill University/Health Center has trained at University of California at Berkeley, McGill University, with CIHR CTN. She holds a CIHR New Investigator Award, CIHR grants, and is a recipient of the Rising Star Award in Global Health from Grand Challenges Canada. Her research focus is to develop synergistic packages with point-of-care diagnostics to expedite primary care for HIV and co-infections in vulnerable populations, domestically and internationally. Systematic reviews and meta-analyses, Bayesian methods in Diagnostics, Response to HAART in Cohorts are her other areas of interest.

Coprésidentes du volet Sciences sociales

Gilbert Émond

Gilbert Émond, Ph. D. est professeur agrégé à l’Université Concordia. Il enseigne les processus de consultation et le cours de sexualité en relations humaines. Chercheur engagé depuis 15 ans en prévention du VIH et sur l’homophobie, il a mis sur pied la Cohorte Oméga et fait partie de l’équipe de chercheurs de SPOT à Montréal. Sa thèse en communication portait sur la séduction, l’expérience sexuelle des hommes gais et la prévention du VIH.

Christine Vezina

Me Christine Vézina termine un doctorat en droit à l’Université de Montréal sur la contribution des organismes communautaires à la mise en œuvre du droit à la santé des personnes vivant avec le VIH ou vulnérables au VIH au Québec. Elle s’intéresse, dans une perspective de sociologie juridique, aux droits économiques et sociaux des personnes marginalisées. Impliquée dans la lutte au VIH depuis 2002, elle a été coopérante volontaire au Niger, responsable du programme sur les droits de la personne et le VIH de la COCQ-Sida et est toujours membre du conseil d’administration du Réseau juridique canadien sur le VIH/sida.

Représentant communautaire

Bruno Lemay

Today, He is the director/founder of the Portail VIH/sida du Québec, a provincial community organization providing information on HIV and its treatment and innovative learning tools.

Membres du comité consultatif

Directeur Général
Andrew brings with him a breadth of experience through the positions he has held at CIHR since 2000. Since 2008, Andrew was the Associate Director of the CIHR HIV/AIDS Research Initiative with particular responsibilities for the Canadian HIV Vaccine Initiative and the HIV/AIDS Community-Based Research Program. Previously at CIHR he held the roles of Senior Policy Advisor and Director of Communications. Prior to working at CIHR, Andrew worked on Parliament Hill, most recently working for Dr. Peter Adams, Member of Parliament and Chair of the Government Caucus on Post Secondary Education and Research.

Robert O'Neill

Ancien Directeur Général d'ACRV
Bob O'Neill has worked for many years as a Health Research Administrator. He is currently the Executive Director of CAHR. Prior to that, he worked with the Canadian HIV Trials Network for two decades, initially as Administrator and subsequently as Director of its International Program. During the 1980’s, he served as Assistant Director of the Nova Scotia Red Cross Blood Donor Program, Director of the Canadian Hemophilia Society (CHS) Ontario Chapter and Director of the CHS’ Task Force on AIDS. On a volunteer basis, Bob has served as Director of the Canada-Africa Prevention Trials Network and has participated on a number of committees and review panels.

Jonathan Angel

Président de l’ACRV
Following training in Toronto, Vancouver and Boston, Dr. Angel joined the Division of Infectious Diseases, at the Ottawa General Hospital in 1995. Since that time he has been involved in laboratory based and clinical research as well as teaching and patient care. His research, supported by the CIHR, CanFAR, a Career Scientist Award from the OHTN, is focused on understanding how HIV damages the immune system and how these insights can potentially lead to new therapies. Dr. Angel is currently a Professor of Medicine at the University of Ottawa and the Director of the HIV Clinic at the Ottawa Hospital.

Brian Conway

In addition to coordinating the first year “Doctor, Patient and Society” for the UBC medical school and supervising several dozen undergraduate, graduate and post-doctoral students over the past decade, Dr. Conway is deeply involved in a range of HIV-related research and clinical practice efforts. Over the past 5 years, he has played a leadership role in the development of novel strategies for the delivery of care for HIV, HCV, genital herpes and other infections in the inner city. These strategies have emphasized the simplification of therapeutic options and integration of medical, addiction and psychological aspects of care. He holds significant research funding to develop a model for the treatment of HCV & HIV infection within a directly observed therapy (DOT) program, focusing on the treatment of intravenous drug users. His programs have received a number of awards for their innovation and success, including the Health Employers Association of British Columbia Award of Excellence in 2008. He was the Francophone of The Year in British Columbia in 2007, for his work in the development of culturally and linguistically optimized systems of care for minority populations.

He is a peer reviewer for 13 medical journals and the primary or senior author of more than 120 peer-reviewed publications. He has been an invited speaker at many international HIV conferences and meetings dealing with HIV.

Dr. Conway received his medical education at McGill University, from which he graduated in 1982 before completing his internship and residency at Queen Elizabeth Hospital and Royal Victoria Hospital, respectively. He completed a specialty fellowship in infectious diseases at the University of Manitoba in 1988, and a post-doctoral fellowship in HIV/AIDS at Harvard University in 1990. His first staff appointment was as an Assistant Professor at the University of Ottawa in 1990. He moved to the University of British Columbia in 1994, where he is now a tenured Full Professor.